Events

Sutro Biopharma to Present at the Cowen and Company 39th Annual Health Care Conference

SOUTH SAN FRANCISCO, Calif., March 5, 2019 –Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that Bill Newell, Chief Executive Officer, will present at the Cowen.. Read More →

Sutro to Present at 37th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 3, 2019 –Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that Bill Newell, Chief Executive Officer, will present at the 37th.. Read More →

Sutro to Participate in the 30th Annual Piper Jaffray Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 26, 2018  — Sutro Biopharma, Inc. (Nasdaq: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application.. Read More →

Cancer’s Next-Gen Smart Bomb: Who Will Be First To Weaponize? – InVivo

https://invivo.pharmamedtechbi.com/IV005100/Cancers-NextGen-Smart-Bomb-Who-Will-Be-First-To-Weaponize    .. Read More →

Biotechnology: Saving Lives & Transforming Healthcare in the 21st Century

Modern biotechnology is a young industry. But in just a few decades, the entrepreneurs, scientists, researchers and investors working in this field have firmly established themselves.. Read More →

BioTech Nation Radio with CEO Bill Newell

NPR and BioTech Nation interview Sutro’s CEO William Newell to learn more about the next generation of cancer therapeutics. Click here to listen to the.. Read More →

Sutro Biopharma Receives the Pantheon 2015 DiNA Outstanding Partner Award by the California Life Sciences Association

SAN FRANCISCO, Nov. 18, 2015 /PRNewswire/ — Sutro Biopharma today announced that it was awarded the Outstanding Partner Award, at the California Life Sciences Association (CLSA) annual Pantheon.. Read More →

FierceBiotech names Sutro Biopharma as one of its “Fierce 15” Biotech Companies of 2014

  San Francisco, CA – September 22, 2014 – Sutro Biopharma today announced that it has been named by FierceBiotech as one of 2014’s Fierce.. Read More →

Sutro Biopharma’s Xpress CF Technology Nominated for Best Scientific Innovation by World ADC

On July 1, 2014, World ADC announced the nominees for the World ADC Awards, 2014. Sutro Biopharma’s cell free expression system, Xpress CF™, has made.. Read More →

EnWave Signs Commercial License with Sutro Biopharma for powderREV® Technology

Press release published by EnWave Corporation regarding the recent agreement with Sutro Biopharma, Inc. Read more.. Read More →

Antibody-Drug Conjugates and Cancer Treatment: Making “Smart Bombs” Smarter

Scientific American Guest Blog Antibody-Drug Conjugates and Cancer Treatment: Making “Smart Bombs” Smarter By: Trevor J. Hallam Read More.. Read More →

Sutro Biopharma’s Trevor Hallam offers a glimpse into the future of drug design

12/5/2011 – BioPharm International Podcast (3of3): Sutro Biopharma’s Trevor Hallam offers a glimpse into the future of drug design By: Trevor J. Hallam.. Read More →

Sutro Biopharma’s Trevor Hallam describes a future cGMP manufacturing facility

BioPharm International Podcast (2of3): Sutro Biopharma’s Trevor Hallam describes a future cGMP manufacturing facility By: Trevor J. Hallam.. Read More →

Sutro Biopharma and Cell-Free Protein Expression Systems

BioPharm International Podcast (1of3): Sutro Biopharma and Cell-Free Protein Expression Systems By: Trevor J. Hallam.. Read More →

Industrializing Design, Development, and Manufacturing of Therapeutic Proteins

PHARMACEUTICAL TECHNOLOGY Volume 35, pp. s8-s11 Industrializing Design, Development, and Manufacturing of Therapeutic Proteins By: Trevor J. Hallam, Christopher J. Murray... Read More →

“Unnatural Selection”

BioCentury, The Bernstein Report on BioBusiness January 10, 2011 issue article, “Unnatural Selection” in the Tools & Techniques section by BioCentury Senior Editor, Ms. Susan.. Read More →

Sutro Biopharma and Promising Protein Synthesis Technology

National Science Foundation (NSF) newsletter featuring Sutro Biopharma and Promising Protein Synthesis Technology. Read More.. Read More →